Haemophilia A and B are rare hereditary bleeding disorders caused by a reduction or absence of the activity of the clotting factors VIII (FVIII) and IX (FIX), respectively. 1 After the introduction of safer factors concentrated on treating or preventing bleeding, life expectancy of people with haemophilia (PwH) has increased. 2,3 As PwH are ageing, atherosclerotic cardiovascular diseases (ASCVD) may increasingly occur. 4-7 Many studies suggest ASCVD risk factors are prevalent among PwH. For example, systemic arterial hypertension (SAH) is of utmost relevance, since it is described in up to 60% of PwH aged 30 years or older. 7